News
3h
NDTV Profit on MSNDr. Reddy's Shares Decline After Citi Reduces Target Price Amid Growth ConcernsCiti expressed caution on the growth outlook, particularly around the Canadian GLP-1 market and the highly anticipated launch ...
Eli Lilly poised for 30-50% growth in 12 months with a strong value and growth nexus. Click here to read more on LLY stock.
Lilly Singh's sex education comedy 'Doin' It' has been picked up by Aura Entertainment for release in September.
Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.
Orforglipron is an oral drug from Eli Lilly that’s in trial stage. The New York Times reports that in a trial of over 500 ...
Cardiologists need to embrace the wave of new drugs, say experts, particularly since they can reduce the risk of CVD.
The once-monthly drug is still under study but could provide added convenience and another option for patients.
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Mounjaro has now become available on the NHS for patients in the UK, meaning doctors will have a lot more work on their ...
Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.
Eli Lilly and Company (NYSE:LLY) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 ...
Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical giant that is a key player in the weight loss drug market. The firm’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results